Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

dc.contributor.authorTang, Juanjie
dc.contributor.authorNovak, Tanya
dc.contributor.authorHecker, Julian
dc.contributor.authorGrubbs, Gabrielle
dc.contributor.authorZahra, Fatema Tuz
dc.contributor.authorBellusci, Lorenza
dc.contributor.authorPourhashemi, Sara
dc.contributor.authorChou, Janet
dc.contributor.authorMoffitt, Kristin
dc.contributor.authorHalasa, Natasha B.
dc.contributor.authorSchwartz, Stephanie P.
dc.contributor.authorWalker, Tracie C.
dc.contributor.authorTarquinio, Keiko M.
dc.contributor.authorZinter, Matt S.
dc.contributor.authorStaat, Mary A.
dc.contributor.authorGertz, Shira J.
dc.contributor.authorCvijanovich, Natalie Z.
dc.contributor.authorSchuster, Jennifer E.
dc.contributor.authorLoftis, Laura L.
dc.contributor.authorCoates, Bria M.
dc.contributor.authorMack, Elizabeth H.
dc.contributor.authorIrby, Katherine
dc.contributor.authorFitzgerald, Julie C.
dc.contributor.authorRowan, Courtney M.
dc.contributor.authorKong, Michele
dc.contributor.authorFlori, Heidi R.
dc.contributor.authorMaddux, Aline B.
dc.contributor.authorShein, Steven L.
dc.contributor.authorCrandall, Hillary
dc.contributor.authorHume, Janet R.
dc.contributor.authorHobbs, Charlotte V.
dc.contributor.authorTremoulet, Adriana H.
dc.contributor.authorShimizu, Chisato
dc.contributor.authorBurns, Jane C.
dc.contributor.authorChen, Sabrina R.
dc.contributor.authorMoon, Hye Kyung
dc.contributor.authorLange, Christoph
dc.contributor.authorRandolph, Adrienne G.
dc.contributor.authorKhurana, Surender
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2023-08-03T12:47:33Z
dc.date.available2023-08-03T12:47:33Z
dc.date.issued2022-08-12
dc.description.abstractCorrection to: Nature Communications 10.1038/s41467-022-30649-1, published online 27 May 2022
dc.eprint.versionFinal published version
dc.identifier.citationTang J, Novak T, Hecker J, et al. Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C. Nat Commun. 2022;13(1):4732. Published 2022 Aug 12. doi:10.1038/s41467-022-32572-x
dc.identifier.urihttps://hdl.handle.net/1805/34711
dc.language.isoen_US
dc.publisherSpringer Nature
dc.relation.isversionof10.1038/s41467-022-32572-x
dc.relation.journalNature Communications
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectViral infection
dc.subjectSARS-CoV-2
dc.subjectAntibodies
dc.subjectVaccines
dc.titleAuthor Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
41467_2022_Article_32572.pdf
Size:
377.34 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: